Cat. #162331
Glioblastoma WHO IV spheroid cell line, NCH711d
Cat. #: 162331
Organism: Human
Tissue: Brain
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Christel Herold-Mende
Institute: Heidelberg University
Primary Citation: Rapp et al. 2017. Acta Neuropathol. 134(2):297-316. PMID: 28332095.
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Glioblastoma WHO IV spheroid cell line, NCH711d
- Cancer: Brain
- Organism: Human
- Tissue: Brain
- Growth properties: Mixed - adherent and suspension
- Description: Glioblastoma WHO IV spheroid cell line, NCH711d
- Biosafety level: 2
Handling
- Growth medium: serum-free DMEM/F-12: Ham medium, supplemented with 2% B27-admixture (PeloBiotech) and basal fibroblast growth factor (Biomol), epidermal growth factor at 20 ng/ml each, heparin at 5 ng/ml, 1% penicillin/streptomycin
- Temperature: 37°C
- Atmosphere: 5% CO2
References
- Alhalabi et al. 2022. Neuro Oncol. 24(1):39-51. PMID: 34232320.
- Rapp et al. 2017. Acta Neuropathol. 134(2):297-316. PMID: 28332095.
